Capital City Trust Co. FL Has $3.57 Million Stock Position in Laboratory Co. of America Holdings (NYSE:LH)

Capital City Trust Co. FL grew its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH) by 1.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 15,553 shares of the medical research company’s stock after acquiring an additional 223 shares during the period. Capital City Trust Co. FL’s holdings in Laboratory Co. of America were worth $3,567,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in LH. OneDigital Investment Advisors LLC boosted its holdings in Laboratory Co. of America by 115.7% during the third quarter. OneDigital Investment Advisors LLC now owns 6,088 shares of the medical research company’s stock worth $1,361,000 after purchasing an additional 3,265 shares during the last quarter. Alexander Randolph Advisory Inc. purchased a new position in Laboratory Co. of America during the third quarter worth about $955,000. Wealthcare Advisory Partners LLC boosted its holdings in Laboratory Co. of America by 23.9% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 2,543 shares of the medical research company’s stock worth $583,000 after purchasing an additional 490 shares during the last quarter. Mutual of America Capital Management LLC purchased a new position in Laboratory Co. of America during the third quarter worth about $2,316,000. Finally, Barclays PLC boosted its holdings in Laboratory Co. of America by 11.8% during the third quarter. Barclays PLC now owns 620,721 shares of the medical research company’s stock worth $138,718,000 after purchasing an additional 65,356 shares during the last quarter. 95.94% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Laboratory Co. of America news, Director Dwight Gary Gilliland sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $241.00, for a total value of $241,000.00. Following the completion of the transaction, the director now owns 7,712 shares of the company’s stock, valued at $1,858,592. The trade was a 11.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Adam H. Schechter sold 6,121 shares of the company’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $244.62, for a total transaction of $1,497,319.02. Following the completion of the sale, the chief executive officer now directly owns 86,445 shares of the company’s stock, valued at $21,146,175.90. This trade represents a 6.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 19,832 shares of company stock valued at $4,788,995 in the last quarter. Corporate insiders own 0.85% of the company’s stock.

Laboratory Co. of America Price Performance

Shares of NYSE:LH opened at $249.86 on Friday. The company has a 50 day moving average of $238.57 and a 200 day moving average of $231.55. The stock has a market cap of $20.90 billion, a P/E ratio of 28.33, a P/E/G ratio of 1.71 and a beta of 1.07. Laboratory Co. of America Holdings has a 12 month low of $191.97 and a 12 month high of $258.59. The company has a current ratio of 1.44, a quick ratio of 1.30 and a debt-to-equity ratio of 0.67.

Laboratory Co. of America (NYSE:LH) last issued its quarterly earnings data on Thursday, February 6th. The medical research company reported $3.45 EPS for the quarter, beating the consensus estimate of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. As a group, sell-side analysts forecast that Laboratory Co. of America Holdings will post 16.01 EPS for the current fiscal year.

Laboratory Co. of America Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 12th. Shareholders of record on Thursday, February 27th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Thursday, February 27th. This represents a $2.88 dividend on an annualized basis and a yield of 1.15%. Laboratory Co. of America’s dividend payout ratio is presently 32.65%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on LH. Evercore ISI upgraded shares of Laboratory Co. of America from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $260.00 to $265.00 in a report on Tuesday, January 7th. StockNews.com raised shares of Laboratory Co. of America from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. Robert W. Baird lifted their price objective on shares of Laboratory Co. of America from $282.00 to $289.00 and gave the stock an “outperform” rating in a research report on Friday, October 25th. HSBC raised shares of Laboratory Co. of America from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Finally, Piper Sandler lifted their price objective on shares of Laboratory Co. of America from $240.00 to $260.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $265.31.

Laboratory Co. of America Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.